Loading…
CapsoVision, Inc. is projected to rise to $8.00 by 2027, a +19% move from its current price of $6.74. CV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.47 | $6.74 | $7.02 | -0.02% |
| May 30 | $6.36 | $6.74 | $7.14 | -0.05% |
| May 31 | $6.27 | $6.74 | $7.23 | -0.07% |
| Jun 1 | $6.20 | $6.73 | $7.31 | -0.10% |
| Jun 2 | $6.14 | $6.73 | $7.38 | -0.12% |
| Jun 3 | $6.09 | $6.73 | $7.44 | -0.14% |
| Jun 4 | $6.04 | $6.73 | $7.50 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.04 | $6.73 | $7.50 | -0.17% |
| Week 2 | $5.76 | $6.72 | $7.83 | -0.33% |
| Week 3 | $5.56 | $6.71 | $8.10 | -0.50% |
| Week 4 | $5.39 | $6.70 | $8.32 | -0.67% |
| Week 5 | $5.24 | $6.68 | $8.52 | -0.83% |
| Week 6 | $5.11 | $6.67 | $8.71 | -1.00% |
| Week 7 | $5.00 | $6.66 | $8.88 | -1.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CapsoVision, Inc. is a medical technology company that manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products.
The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
CapsoVision, Inc. (CV) is a healthcare company focused on endoscopic imaging devices for gastrointestinal applications. It trades with a current price of $6.64 and a market cap of $331.76M, and it is ranked 3420.
The current price sits at the start of a multi-year forecast path that shows rising average values in the years ahead, beginning with 2026 at $6.64 and moving higher in subsequent years toward substantial long‑term upside. The forecast includes a sequence of increasing average prices through 2027–2035, then more pronounced gains by 2040 and 2050, reflecting an optimistic long‑run outlook.
A major floor 34.0% below — a decisive break under it would weaken the trend.
The nearest floor, 19.9% below — buyers have tended to step in here.
The nearest ceiling, 11.3% above — a clean break opens room to run.
A major ceiling 28.9% above — clearing it would confirm fresh momentum.
Key CV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.65 | Buy | $6.68 | Buy |
| MA 10 | $6.69 | Buy | $6.71 | Buy |
| MA 20 | $6.89 | Sell | $6.72 | Buy |
| MA 50 | $6.71 | Buy | $6.58 | Buy |
| MA 100 | $6.16 | Buy | $6.43 | Buy |
| MA 200 | $6.04 | Buy | $5.99 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.83 | Neutral |
| Stoch RSI (14) | 42.43 | Neutral |
| CCI (20) | -33.52 | Neutral |
| Williams %R (14) | -59.57 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -5.34 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 40.43 | Neutral |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 58.58 | Neutral |
| Momentum (10) | -0.41 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 6.69 | Buy |
| ADX (14) | 8.75 | Neutral |
| ATR (14) | 0.23 | Info |
The 30-day technical picture is currently bullish. RSI14 is 50, with the SMA50 at $6.66 and the SMA200 at $6.01, signaling a roughly sideways to modestly bullish trajectory around the current price. Near-term support sits at $5.40 and resistance at $7.50, with the 30-day price range spanning from $4.98 to $8.85.
The asset shows notable volatility, with annualized volatility at 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.64 | $6.74 | $10.85 | 0% | Neutral | |
| $5.68 | $8.00 | $12.20 | +19% | Neutral | |
| $6.23 | $9.35 | $15.21 | +39% | Bullish | |
| $9.31 | $14.77 | $25.23 | +119% | Bullish | |
| $10.27 | $17.15 | $30.52 | +154% | Bullish | |
| $10.78 | $18.88 | $34.81 | +180% | Bullish | |
| $11.33 | $20.78 | $39.54 | +208% | Bullish | |
| $10.84 | $20.78 | $40.67 | +208% | Bullish | |
| $12.05 | $24.15 | $48.47 | +258% | Bullish | |
| $13.80 | $28.85 | $59.31 | +328% | Bullish | |
| $19.21 | $42.70 | $96.69 | +534% | Bullish | |
| $58.32 | $129.61 | $298.10 | +18.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.64 | $6.74 | $8.04 | +0.00% |
| June 2026 | $5.55 | $6.67 | $8.33 | -0.97% |
| July 2026 | $5.39 | $6.60 | $8.45 | -1.20% |
| August 2026 | $5.67 | $7.04 | $9.21 | +6.79% |
| September 2026 | $5.89 | $7.40 | $9.84 | +5.05% |
| October 2026 | $5.77 | $7.33 | $9.89 | -0.96% |
| November 2026 | $5.82 | $7.47 | $10.20 | +1.89% |
| December 2026 | $6.06 | $7.85 | $10.85 | +5.10% |
Click any year to see its month-by-month CV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CV to range from $4.64 to $10.85 through 2026. The $6.74 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CV price prediction for 2027 points to an average of $8.00 (low $5.68, high $12.20) — a potential gain of +19% on today's $6.74. A consolidation phase looks the most probable path here.
In 2028, CV is projected to trade between $6.23 and $15.21, averaging $9.35 — a potential gain of +39% from today's $6.74. That is up +17% on the projected 2027 average. Momentum favours further upside here.
CapsoVision, Inc.'s 2029 outlook centres on $14.77, within a $9.31 to $25.23 range. That is up +58% on the projected 2028 average. That marks a +119% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CV could reach as high as $30.52, with a base case around $17.15 and support toward $10.27 — roughly +154% from $6.74. Momentum favours further upside here.
Expect CV to range from $10.78 to $34.81 through 2031. The $18.88 average target implies a +180% move from current prices. That is up +10% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CV price prediction for 2032 points to an average of $20.78 (low $11.33, high $39.54) — a potential gain of +208% on today's $6.74. Momentum favours further upside here.
In 2033, CV is projected to trade between $10.84 and $40.67, averaging $20.78 — a potential gain of +208% from today's $6.74. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
CapsoVision, Inc.'s 2034 outlook centres on $24.15, within a $12.05 to $48.47 range. That is up +16% on the projected 2033 average. That marks a +258% change versus current levels. Momentum favours further upside here.
By 2035, CV could reach as high as $59.31, with a base case around $28.85 and support toward $13.80 — roughly +328% from $6.74. Buyers look set to stay in control over this stretch.
Expect CV to range from $19.21 to $96.69 through 2040. The $42.70 average target implies a +534% move from current prices. That is up +48% on the projected 2035 average. Momentum favours further upside here.
The CV price prediction for 2050 points to an average of $129.61 (low $58.32, high $298.10) — a potential gain of +18.2x on today's $6.74. Buyers look set to stay in control over this stretch.
Investing $1,000 in CV today (≈ 148.367953 CV) could be worth
$19,229.88
+$18,229.88 (+1823%) by 2050 · US Dollar
Based on the average projected CV price of $129.61 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVwould be worth at today's price.
$1,000 invested in CV on Jul 2, 2025 (≈ 285.714286 CV) would be worth
$1,925.71
+$925.71 (+92.6%) today · 1.93× · US Dollar
Based on a CV entry price of $3.5 vs. today's $6.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.48 | $1,040.12 | +4.0% |
| 1 month ago | $6.37 | $1,058.08 | +5.8% |
| 3 months ago | $5.08 | $1,326.77 | +32.7% |
| 6 months ago | $5.59 | $1,205.72 | +20.6% |
| All time ago | $3.5 | $1,925.71 | +92.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CV forecast.
Our base-case forecast reaches $13.00 around 2029.
Implied market cap at $13.00: $649.53M
The multi-year forecast lays out a path of substantial upside across the coming decades. The 2026 forecast shows an average price of $6.64 with a neutral sentiment, progressing to 2027 average $7.88 and 2028 average $9.50, then 2029 average $15.40 and 2030 average $17.65 with bullish sentiment and rising ROI. By 2035 the average is projected at $30.81 and the trend continues higher to 2040 average of $45.90 with a 591.2 ROI and bullish sentiment, and to 2050 average of $142.59 with a 2047.4 ROI and bullish sentiment.
The 2040 and 2050 forecast paths imply the potential for very large upside, with 2040 maxes at $105.56 and 2050 maxes at $327.95. The model also shows substantial year-by-year momentum through 2031–2035 (e.g., 2031 avg $19.60, 2032 $21.74, 2033 $21.42, 2034 $25.43, 2035 $30.81) before accelerating into the 2040s. These are estimates and not guarantees; outcomes depend on market conditions and other factors.
Tap a question to reveal the answer.
2030 forecast: min $10.25, avg $17.65, max $32.13, ROI 165.8, sentiment BULLISH.
Forecasts show a rising average price in several years (e.g., 2027 avg $7.88; 2028 avg $9.50; 2029 avg $15.40; 2030 avg $17.65; 2040 avg $45.90; 2050 avg $142.59) with bullish sentiment in later years, but these are estimates, not guarantees.
Yes. The 2040 forecast max is $105.56 and the 2050 forecast max is $327.95, indicating potential to exceed $100 by 2040 (and further by 2050).
Current price $6.64; Market cap $331.76M. Rank 3420.
ThirtyDayRange low $4.98; high $8.85.
CapsoVision, Inc. Community Discussion
0Share your CapsoVision, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.